<?xml version="1.0" encoding="UTF-8"?><iati-activities generated-datetime="2026-08-27T16:35:04.0149861+01:00" version="2.03"><iati-activity last-updated-datetime="2026-07-31T00:00:00+00:00" xml:lang="en" default-currency="USD" hierarchy="1"><iati-identifier>GB-CHC-1099776-Z3</iati-identifier><reporting-org xml:lang="en" ref="GB-CHC-1099776" type="21"><narrative>Malaria Consortium</narrative></reporting-org><title xml:lang="en"><narrative>Planning grant to expand REACH in Nigeria</narrative></title><description xml:lang="en" type="1"><narrative>Planning grant to expand REACH in Nigeria</narrative></description><participating-org xml:lang="en" ref="DAC-1601" type="60" role="1"><narrative>Bill &amp; Melinda Gates Foundation</narrative></participating-org><activity-status code="4" /><activity-date type="2" iso-date="2023-07-11" /><activity-date type="3" iso-date="2023-12-31" /><activity-date type="4" iso-date="2023-12-31" /><contact-info type="1"><organisation><narrative>Malaria Consortium</narrative></organisation><person-name><narrative>Malaria Consortium</narrative></person-name><email>iati@malariaconsortium.org</email><mailing-address><narrative>The Green House, 244-254 Cambridge Heath Road, London, E2 9DA, United Kingdom</narrative></mailing-address></contact-info><recipient-country code="NG" percentage="100.000000000000000000" /><sector vocabulary="1" code="12262" percentage="100.000000000000000000"><narrative>Malaria control</narrative></sector><default-flow-type code="10" /><default-finance-type code="110" /><default-tied-status code="5" /><budget type="1"><period-start iso-date="2023-07-11" /><period-end iso-date="2023-12-31" /><value value-date="2023-07-11" currency="USD">70002</value></budget><transaction><transaction-type code="1" /><transaction-date iso-date="2023-11-17" /><value currency="USD" value-date="2023-11-17">70002</value><provider-org provider-activity-id="" ref="DAC-1601"><narrative>Bill &amp; Melinda Gates Foundation</narrative></provider-org><receiver-org receiver-activity-id="" ref=""><narrative /></receiver-org><disbursement-channel code="2" /><flow-type code="10" /><finance-type code="110" /><tied-status code="5" /></transaction><transaction><transaction-type code="1" /><transaction-date iso-date="2025-03-17" /><value currency="USD" value-date="2025-03-17">-35930</value><provider-org provider-activity-id="" ref="DAC-1601"><narrative>Bill &amp; Melinda Gates Foundation</narrative></provider-org><receiver-org receiver-activity-id="" ref=""><narrative /></receiver-org><disbursement-channel code="2" /><flow-type code="10" /><finance-type code="110" /><tied-status code="5" /></transaction><related-activity ref="GB-CHC-1099776-Z3-NG" type="2" /></iati-activity><iati-activity last-updated-datetime="2026-07-31T00:00:00+00:00" xml:lang="en" default-currency="USD" hierarchy="2"><iati-identifier>GB-CHC-1099776-Z3-NG</iati-identifier><reporting-org xml:lang="en" ref="GB-CHC-1099776" type="21"><narrative>Malaria Consortium</narrative></reporting-org><title xml:lang="en"><narrative>Planning grant to expand REACH in Nigeria [Nigeria]</narrative></title><description xml:lang="en" type="1"><narrative>Planning grant to expand REACH in Nigeria [Nigeria]</narrative></description><participating-org xml:lang="en" ref="GB-CHC-1099776" type="21" role="4"><narrative>Malaria Consortium</narrative></participating-org><activity-status code="4" /><activity-date type="2" iso-date="2023-07-11" /><activity-date type="3" iso-date="2023-12-31" /><activity-date type="4" iso-date="2023-12-31" /><contact-info type="1"><organisation><narrative>Malaria Consortium</narrative></organisation><person-name><narrative>Malaria Consortium</narrative></person-name><email>iati@malariaconsortium.org</email><mailing-address><narrative>The Green House, 244-254 Cambridge Heath Road, London, E2 9DA, United Kingdom</narrative></mailing-address></contact-info><recipient-country code="NG" percentage="100.000000000000000000" /><sector vocabulary="1" code="12262" percentage="100.000000000000000000"><narrative>Malaria control</narrative></sector><default-flow-type code="10" /><default-finance-type code="110" /><default-tied-status code="5" /><transaction><transaction-type code="4" /><transaction-date iso-date="2023-12-31" /><value currency="USD" value-date="2023-12-31">33452</value><provider-org provider-activity-id="" ref=""><narrative /></provider-org><receiver-org receiver-activity-id="" ref=""><narrative /></receiver-org><disbursement-channel code="2" /><flow-type code="10" /><finance-type code="110" /><tied-status code="5" /></transaction><transaction><transaction-type code="4" /><transaction-date iso-date="2024-03-31" /><value currency="USD" value-date="2024-03-31">613</value><provider-org provider-activity-id="" ref=""><narrative /></provider-org><receiver-org receiver-activity-id="" ref=""><narrative /></receiver-org><disbursement-channel code="2" /><flow-type code="10" /><finance-type code="110" /><tied-status code="5" /></transaction><transaction><transaction-type code="4" /><transaction-date iso-date="2024-06-30" /><value currency="USD" value-date="2024-06-30">8</value><provider-org provider-activity-id="" ref=""><narrative /></provider-org><receiver-org receiver-activity-id="" ref=""><narrative /></receiver-org><disbursement-channel code="2" /><flow-type code="10" /><finance-type code="110" /><tied-status code="5" /></transaction><related-activity ref="GB-CHC-1099776-Z3" type="1" /></iati-activity></iati-activities>
